October 2018 – Policy & Medicine

CMS Submits Part D and Medicare Advantage Drug Pricing Proposal to Office of Management and Budget

CMS Releases Proposed CY20 Medicare Advantage/Part D Rule

HHS Unveils New Plan for Prescription Prices for Medicare Part B Drugs

Second Letter from OPDP Issued Regarding the Bad Ad Campaign

Upcoming Webinar on Open Payment Data Trends

MannKind Corporation Receives Warning Letter from Facebook Post

FDA Releases Set of Guidances on Transdermal and Topical Delivery Systems

FDA Publishes Guidance on Product Identifiers Under the Drug Supply Chain Security Act

PTAC Recommendations Seemingly Being Ignored

HHS Proposes New DTC Advertising Requirement